154 related articles for article (PubMed ID: 111787)
21. 1,25-dihydroxycholecalciferol and parathormone: effects on isolated osteoclast-like and osteoblast-like cells.
Wong GL; Luben RA; Cohn DV
Science; 1977 Aug; 197(4304):663-5. PubMed ID: 195343
[TBL] [Abstract][Full Text] [Related]
22. The influence of 1 alpha,25- and 24(R),25-dihydroxyvitamin D3 on bone constituents during early mineralization in the rat.
Vukicević S; Bagi C; Vujicić G; Krempien B; Stavljenić A; Herak M
Bone Miner; 1986 Oct; 1(5):383-96. PubMed ID: 3509782
[TBL] [Abstract][Full Text] [Related]
23. Comparison of fetal rat limb bones and neonatal mouse calvaria: effects of parathyroid hormone and 1,25-dihydroxyvitamin D3.
Stern PH; Krieger NS
Calcif Tissue Int; 1983; 35(2):172-6. PubMed ID: 6687826
[TBL] [Abstract][Full Text] [Related]
24. The effect of parathyroid hormone and vitamin D3 metabolites on CaBP synthesis by embryonic duodenum, in vitro.
Parkes CO; Reynolds JJ
Horm Metab Res; 1978 Jan; 10(1):75-7. PubMed ID: 564862
[TBL] [Abstract][Full Text] [Related]
25. The unique action for bone metabolism of 1 alpha,25-(OH)2D3-26,23-lactone.
Kiyoki M; Kurihara N; Ishizuka S; Ishii S; Hakeda Y; Kumegawa M; Norman AW
Biochem Biophys Res Commun; 1985 Mar; 127(2):693-8. PubMed ID: 3838477
[TBL] [Abstract][Full Text] [Related]
26. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
27. Failure of 1, 25 dihydroxycholecalciferol (1, 25-(OH) 2-D3) to modify cyclic AMP levels in parathyroid hormone-treated and untreated bone cells.
Peck WA; Dowling I
Endocr Res Commun; 1976; 3(2):157-66. PubMed ID: 182450
[TBL] [Abstract][Full Text] [Related]
28. The action of two metabolites of vitamin D3; 25,26-dihydroxycholecalciferol (25,26(OH)2D3) and 24, 25-dihydroxycholecalciferol (24,25(OH)2D3) on bone resorption.
Peacock M; Taylor GA; Redel J
FEBS Lett; 1976 Mar; 62(3):248-50. PubMed ID: 1278366
[No Abstract] [Full Text] [Related]
29. Direct effects of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth zone and resting zone chondrocyte membrane alkaline phosphatase and phospholipase-A2 specific activities.
Schwartz Z; Schlader DL; Swain LD; Boyan BD
Endocrinology; 1988 Dec; 123(6):2878-84. PubMed ID: 3264240
[TBL] [Abstract][Full Text] [Related]
30. Role of carbonic anhydrase in bone resorption induced by 1,25 dihydroxyvitamin D3 in vitro.
Hall GE; Kenny AD
Calcif Tissue Int; 1985 Mar; 37(2):134-42. PubMed ID: 3924369
[TBL] [Abstract][Full Text] [Related]
31. Hydroxycholecalciferols modulate parathyroid hormone and calcitonin sensitive adenylyl cyclase in bone and kidney of rats. A possible physiological role for 24,25-dihydroxy vitamin D3.
Gordeladze JO; Gautvik KM
Biochem Pharmacol; 1986 Mar; 35(6):899-902. PubMed ID: 3485429
[TBL] [Abstract][Full Text] [Related]
32. 1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.
Berl T; Berns AS; Hufer WE; Hammill K; Alfrey AC; Arnaud CD; Schrier RW
Ann Intern Med; 1978 Jun; 88(6):774-80. PubMed ID: 208439
[TBL] [Abstract][Full Text] [Related]
33. Renal effect of vitamin D metabolites: evidence for the essential role of the 25(OH) group.
Friedlaender MM; Kornberg Z; Wald H; Popovtzer MM
Am J Physiol; 1983 Jun; 244(6):F674-8. PubMed ID: 6602555
[TBL] [Abstract][Full Text] [Related]
34. 1,25-Dihydroxyvitamin D3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation.
Beresford JN; Gallagher JA; Russell RG
Endocrinology; 1986 Oct; 119(4):1776-85. PubMed ID: 3489608
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the metabolism of 25-hydroxyvitamin D3 in primary cultures of chick kidney cells.
Trechsel U; Bonjour JP; Fleisch H
J Clin Invest; 1979 Jul; 64(1):206-17. PubMed ID: 109470
[TBL] [Abstract][Full Text] [Related]
36. Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites.
Somerville PJ; Kaye M
Kidney Int; 1978 Sep; 14(3):245-54. PubMed ID: 723151
[TBL] [Abstract][Full Text] [Related]
37. Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture.
Hale LV; Kemick ML; Wuthier RE
J Bone Miner Res; 1986 Dec; 1(6):489-95. PubMed ID: 3509742
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
39. Parathyroid hormone related peptide (1-34) and 1,25-dihydroxyvitamin D, have no additive effects on bone tartrate resistant acid phosphatase activity in fetal rat calvaria cultures.
de la Piedra C; Traba ML; Municio MJ; Torres R
Horm Metab Res; 1993 Aug; 25(8):417-20. PubMed ID: 8225185
[TBL] [Abstract][Full Text] [Related]
40. 1,25-dihydroxyvitamin D-3 and 24,25-dihydroxyvitamin D-3 affect parathormone (PTH) -sensitive adenylate cyclase activity and alkaline phosphatase secretion of osteoblastic cells through different mechanisms of action.
Klem KH; Jablonski G; Saether O; Jarosz G; Gautvik KM; Gordeladze JO
Biochim Biophys Acta; 1990 Sep; 1054(3):304-10. PubMed ID: 2169895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
